Clinical trial · Observational
Evaluation of Hereditary Cancer Educational Videos
NCT06157801CI-TRIAL-00122071active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To learn if educational videos can help participants be more informed about hereditary cancers (ones that run in the family).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hereditary Cancer | Hereditary Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Interview Study | Behavioral | — | UNRESOLVED |
| Survey Study | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Interview Study
- description
- In the interview study, participants will watch the video, then complete an interview. This will take about 50 minutes.
- interventionNames
- Behavioral: Interview Study
- label
- Survey Study
- description
- In the survey study, participants will complete a survey about your education and complete a quick test about your knowledge of hereditary cancer. Participants will then watch the video. complete another survey similar to the one before the video. This should take about 30 minutes.
- interventionNames
- Behavioral: Survey Study
Primary outcomes (1)
- measure
- Hereditary Cancer Multidimensional Measure of Informed Choice Questionnaires
- timeFrame
- through study completion; an average of 1 year
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Participants of The Harris Health System Lyndon B. Johnson (LBJ) Hospital outpatient oncology clinics (i.e., Gynecologic Oncology, Medical Oncology). 2. 18 years of age or older. 3. Speaks and/or reads English or Spanish. 4. Has a pathogenic or likely pathogenic variant (mutation) in BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, and/or EPCAM on germline genetic testing. 5. Has a documented genetic testing results disclosure encounter (i.e. telephone call, follow-up appointment). Exclusion Criteria: 1. No longer receives outpatient care at LBJ Hospital at time of recruitment. 2. Has only a variant of uncertain significance in BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, and/or EPCAM. 3. Has only a pathogenic or likely pathogenic variant in gene other than BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, or EPCAM. 4. Is unwilling, unable, or requires a legally authorized representative to provide informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.